(PME) Sentry Select Primary - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA81733D1050

PME: Metals, Mining, Gold, Minerals, Stocks, Equities, Commodities

Sentry Select Primary Metals Corp (TO:PME) is an open-ended equity mutual fund managed by CI Investments Inc., established on April 23, 2007. The fund focuses on global public equity markets, targeting companies involved in the production and exploration of metals and minerals. Its strategy emphasizes value stocks across diversified market capitalizations, employing a combination of top-down macroeconomic analysis and bottom-up stock selection. The funds investment approach prioritizes fundamental analysis, evaluating factors such as profitability, liquidity, operating efficiency, cash flow, and management quality. Performance is benchmarked against the S&P/TSX Composite Index and a composite index comprising 50% S&P/TSX Diversified Mining Index and 50% S&P/TSX Global Gold Index.

From a technical perspective, PME shares have shown a stable trend, with the 20-day SMA aligning with the current price at 2.57, slightly above the 50-day SMA of 2.47 and the 200-day SMA of 2.31. The Average True Range (ATR) of 0.06 indicates low volatility. The average 20-day trading volume is 3,950 shares, reflecting limited liquidity.

Fundamentally, the fund has a market capitalization of 35.74M CAD, with a trailing P/E ratio of 2.10. However, the forward P/E is currently undefined. The price-to-book (P/B) ratio is absent, and the price-to-sales (P/S) ratio stands at 2.59. The return on equity (RoE) is negative at -28.88%, signaling challenges in profitability.

Based on the intersection of technical and fundamental data, the 3-month outlook for Sentry Select Primary Metals Corp (TO:PME) suggests a stable to slightly bullish trajectory. The alignment of the 20-day and 50-day SMAs above the 200-day SMA indicates potential upward momentum, supported by the low ATR suggesting reduced near-term volatility. However, the negative RoE and limited trading volume may constrain significant price appreciation. Expect the stock to trade within a narrow range, potentially testing the upper bound of its current SMA structure.

Additional Sources for PME Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

PME Stock Overview

Market Cap in USD 28m
Sector Basic Materials
Industry Gold
GiC Sub-Industry Gold
IPO / Inception

PME Stock Ratings

Growth Rating 45.1
Fundamental -
Dividend Rating 65.5
Rel. Strength 38.5
Analysts -
Fair Price Momentum 2.67 CAD
Fair Price DCF 3.54 CAD

PME Dividends

Dividend Yield 12m 7.19%
Yield on Cost 5y 12.24%
Annual Growth 5y 0.00%
Payout Consistency 87.7%

PME Growth Ratios

Growth Correlation 3m 61.2%
Growth Correlation 12m 90.8%
Growth Correlation 5y 12.5%
CAGR 5y 12.98%
CAGR/Max DD 5y 0.32
Sharpe Ratio 12m -0.11
Alpha 21.50
Beta 1.129
Volatility 36.65%
Current Volume 2.4k
Average Volume 20d 4.9k
What is the price of PME stocks?
As of April 28, 2025, the stock is trading at CAD 2.70 with a total of 2,400 shares traded.
Over the past week, the price has changed by +0.37%, over one month by -3.75%, over three months by +12.11% and over the past year by +29.24%.
Is Sentry Select Primary a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Sentry Select Primary (TO:PME) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 45.13 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PME as of April 2025 is 2.67. This means that PME is currently overvalued and has a potential downside of -1.11%.
Is PME a buy, sell or hold?
Sentry Select Primary has no consensus analysts rating.
What are the forecast for PME stock price target?
According to ValueRays Forecast Model, PME Sentry Select Primary will be worth about 3.1 in April 2026. The stock is currently trading at 2.70. This means that the stock has a potential upside of +13.33%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 3.1 13.3%